| 000 | 01550 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513043351.0 | ||
| 264 | 0 | _c19950718 | |
| 008 | 199507s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/0014-2999(95)00016-e _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNakayama, K | |
| 245 | 0 | 0 |
_aEffects of M16209 on insulin secretion in isolated, perfused pancreases of normal and diabetic rats. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cMar 1995 |
||
| 300 |
_a85-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAldehyde Reductase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzofurans _xpharmacology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xmetabolism |
| 650 | 0 | 4 |
_aHydantoins _xpharmacology |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aInsulin _xmetabolism |
| 650 | 0 | 4 | _aInsulin Secretion |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPancreas _xdrug effects |
| 650 | 0 | 4 | _aPerfusion |
| 650 | 0 | 4 |
_aPotassium Channels _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aStreptozocin |
| 700 | 1 | _aMurakami, N | |
| 700 | 1 | _aOhta, M | |
| 700 | 1 | _aKato, K | |
| 700 | 1 | _aNotsu, T | |
| 700 | 1 | _aMizota, M | |
| 700 | 1 | _aMiwa, I | |
| 700 | 1 | _aOkuda, J | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 276 _gno. 1-2 _gp. 85-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0014-2999(95)00016-e _zAvailable from publisher's website |
| 999 |
_c7781064 _d7781064 |
||